Main menu button

News

Analysis, Cherry: Yggdrasil and PBM on a roll
30 Aug 2017
Analysis, Cherry: Yggdrasil and PBM on a roll
Equity Research
Analysis, Consilium: Investing in a weak market
29 Aug 2017
Analysis, Consilium: Investing in a weak market
Equity Research
Analysis, Wilson Therapeutics: Promising ahead of autumn
28 Aug 2017
Analysis, Wilson Therapeutics: Promising ahead of autumn
Equity Research
Analysis, TargetEveryone: Fokus on margins again
25 Aug 2017
Analysis, TargetEveryone: Fokus on margins again
Equity Research
Analysids, Fastator: Aggressive goals for Offentliga Hus
25 Aug 2017
Analysids, Fastator: Aggressive goals for Offentliga Hus
Equity Research
Analysis, VA Automotive: Commodities prices behind loss in Q2
23 Aug 2017
Analysis, VA Automotive: Commodities prices behind loss in Q2
Equity Research
Preview, TargetEveryone Q2
22 Aug 2017
Preview, TargetEveryone Q2
Equity Research
22 Aug 2017
Analysis, Episurf: Speed is picking up...
Equity Research
Analysis, Amasten: More acquisitions to come?
21 Aug 2017
Analysis, Amasten: More acquisitions to come?
Equity Research
Comment, Cherry profit warning
17 Aug 2017
Comment, Cherry profit warning
Equity Research
Analysis, Kontigo Care: Growing client base
15 Aug 2017
Analysis, Kontigo Care: Growing client base
Equity Research
Analysis, Oboya: Strong growth under the 2nd quarter
14 Aug 2017
Analysis, Oboya: Strong growth under the 2nd quarter
Equity Research
Analysis, Serneke: Increasing values in Karlastaden
19 Jul 2017
Analysis, Serneke: Increasing values in Karlastaden
Equity Research
Earnings review: Serneke Q2 2017
19 Jul 2017
Earnings review: Serneke Q2 2017
Equity Research
Analysis, Lammhults: Business delayed until later this year
07 Jul 2017
Analysis, Lammhults: Business delayed until later this year
Equity Research
Analysis Sonetel: Focus on Growth
07 Jul 2017
Analysis Sonetel: Focus on Growth
Equity Research
Preview, Serneke: Q2, 2017
07 Jul 2017
Preview, Serneke: Q2, 2017
Equity Research
Analysis, FastPartner: Increased cash flow
06 Jul 2017
Analysis, FastPartner: Increased cash flow
Equity Research
Analysis, Maxkompetens: Cheap growth
04 Jul 2017
Analysis, Maxkompetens: Cheap growth
Equity Research
Analysis, Neurovive: NeuroVive sits on a stronger hand
28 Jun 2017
Analysis, Neurovive: NeuroVive sits on a stronger hand
Equity Research